Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

NCT03172598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Painful Diabetic Peripheral Neuropathy

Interventions

DRUG: MT-8554 low dose
DRUG: MT-8554 middle dose
DRUG: MT-8554 high dose
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation